Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CordovaCannLVRLF +8.75% EBITDA Margin % is 7.88% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 961 Drug Manufacturers companies, CordovaCann ranks worse than 79.4% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. CordovaCann's EBITDA for the
six
months ended in Dec. 2025 was $0.41 Mil. CordovaCann's Revenue for the
six
months ended in Dec. 2025 was $5.15 Mil. Therefore, CordovaCann's EBITDA margin for the quarter that ended in Dec. 2025 was 7.88%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
CordovaCann EBITDA Margin % Related Terms
CordovaCann EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for CordovaCann's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LVRLF vs BUDZ, CTTH, SBFM: EBITDA Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, CordovaCann's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CordovaCann EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CordovaCann's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where CordovaCann's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CordovaCann (LVRLF) has a EBITDA Margin % of 7.88% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CordovaCann and its competitors. According to the industry distribution chart, CordovaCann ranks #763 out of 961 companies in the Drug Manufacturers industry, placing it in the top 79.4%.
Is CordovaCann's EBITDA Margin % too high?
CordovaCann's current EBITDA Margin % is 7.88%. The Drug Manufacturers industry median EBITDA Margin % is 12.49. CordovaCann's value of 7.88% is 36.9% below this industry median. Based on the distribution chart, CordovaCann ranks #763 out of 961 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does CordovaCann's EBITDA Margin % compare to BUDZ and CTTH?
According to the Drug Manufacturers industry distribution chart, CordovaCann ranks #763 out of 961 companies for EBITDA Margin %. This places CordovaCann in the lower half of its industry. The industry median EBITDA Margin % is 12.49. CordovaCann's value of 7.88% is 36.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.49, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CordovaCann's current EBITDA Margin % of 7.88% is 36.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CordovaCann and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CordovaCann's current EBITDA Margin % is 7.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CordovaCann stock overvalued right now?
Based on GuruFocus' analysis, CordovaCann (LVRLF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.08, compared to a current price of $0.03 — trading 56.5% below its estimated fair value. The current EBITDA Margin % is 7.88% and 36.9% below the Drug Manufacturers industry median of 12.49. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For CordovaCann (LVRLF), the current EBITDA Margin % is 7.88% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CordovaCann Corp is a Canadian-domiciled company focused on building a diversified cannabis company. The company provides services and investment capital to the processing and production of vertical markets of the cannabis industry. It aims to accelerate retail growth, invest and scale branded products, and leverage excess capacity for white label manufacturing, to drive company profitability.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LVRLF has been successfully added to your 
